TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership and Insiders Activity

TAYSHA GENE THERAPIES INC (TSHA) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $3.33M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Polen Capital Management is the largest disclosed holder, reporting approximately $3.33M in TSHA holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Polen Capital Management representing the majority of disclosed value.

Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.